Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Glioblastoma

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Glioblastoma:

Pubmed Logo
Control of the G2/M checkpoints after exposure to low doses of ionising radiation: Implications for hyper-radiosensitivity.
Two molecularly distinct G2/M cell cycle arrests are induced after...
21st November, 2009
Institut Curie, Centre de Recherche, Bat. 110-112, Centre universitaire, DNA Repair (Amst). 2009 Nov 17.
DOI Direct Link
Two-Step Synthesis of Multivalent Cancer-Targeting Constructs.
Selective targeting of constructs to pathological cells by conjugating one...
21st November, 2009
School of Biological and Health Systems Engineering, Center for Biomacromolecules. 2009 Nov 19.
DOI Direct Link
CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
Glioblastoma (GBM) is the most aggressive and malignant brain tumor....
20th November, 2009
Centre for Neuroscience and Cell Biology and CIMAGO, University of Cancer Biol Ther. 2010 Jan 17;9(1).
Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.
Recurrent glioblastoma multiforme (GBM), insensitive against most...
19th November, 2009
German Cancer Research Center, Dept of Imaging and Radiooncology, Drug Des Devel Ther. 2009 Feb 6;2:289-301.
Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells.
Our group has recently developed 1-(t)butyl carbamoyl,...
19th November, 2009
Molecular Therapeutics Laboratory, Program in Women's Oncology, Department Drug Des Devel Ther. 2009 Feb 6;2:61-69.

View more research publications.

Press Releases About Glioblastoma:

BioPortfolio Logo
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics 16th November, 2009
JAMAICA PLAIN, Massachusetts, November 16 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced it will give a presentation today at the AACR-NCI-EORTC International Conference Molecular Targets and
New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Cancer Model 10th November, 2009 Peregrine Pharmaceuticals, Inc.
TUSTIN, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody
Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme 26th October, 2009 Ascenta Therapeutics, Inc.
MALVERN, Pa., Oct. 26 /PRNewswire/ -- Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral,
NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma 22nd October, 2009 NexGenix Pharmaceuticals Holdings, Inc.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative
Video: Groundbreaking Project Launched to Improve Brain Cancer Treatments and Outcomes 22nd October, 2009 Swedish Neuroscience Institute
SEATTLE, Oct. 22 /PRNewswire-USNewswire/ -- A major collaborative research project focused on mapping the gene activity in brain tumors was launched today. The goal of the research, known as the Ivy

BioNews Results for Glioblastoma:

RSS Logo
BioPortfolio Logo
Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Th
Pharma Live:  Nov 21 2009 2:54AM Matching: glioblastoma
Questions and answers on the recommendation for the refusal of a change to the marketing authorisation for Ava
Pharma Live:  Nov 20 2009 5:11PM Matching: glioblastoma
European advisory committee declines to recommend Avastin approval for deadly brain cancer
Drug Store News:  Nov 20 2009 7:39PM Matching: glioblastoma
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Temozolomide Teva
Pharma Live:  Nov 20 2009 5:10PM Matching: glioblastoma
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Temomedac
Pharma Live:  Nov 20 2009 5:10PM Matching: glioblastoma
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Glioblastoma Patents:

USPTO Logo
US Patent No.Title
7605266 Azaindole inhibitors of Aurora kinases
7608739 Mitotic kinesin inhibitors
7609061 Demagnetized implant for magnetic resonance imaging
7611692 Gastrin releasing peptide compounds
7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

View more patents.

Companies working in the area of Glioblastoma from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Allos Therapeutics Incorporated

Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments. Since 1994, we have been committed to improving the health...
www.allos.com/        View full profile
Thumbshot

BSD Medical

BSD Medical Corporation (AMEX: BSM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and...
www.bsdmc.com/        View full profile
Thumbshot

EntreMed Incorporated

EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is...
www.entremed.com/        View full profile
Thumbshot

View more Glioblastoma related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Glioblastoma scientists - we have details of around 1290 individuals working on Glioblastoma .


This page has been viewed 1122 times
Recent Search Terms used to find this page: gbm 2009 | glioblastoma report 2009 | clinical results for brain rhabdo after gamma knife surgery for nov 2009 | clinical results for brain rhabdo after gamma knife surgery for nov 2009 | GBM Research Incorporated | gbm 2009 | glioblastoma 2009 | Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma | glioblastoma center of excellence | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Glioblastoma across BioPortfolio, or for Glioblastoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.